Nanobody-functionalized polymersomes for tumor-vessel targeting

Macromol Biosci. 2013 Jul;13(7):938-45. doi: 10.1002/mabi.201300039. Epub 2013 May 21.

Abstract

Targeted carrier systems (e.g., liposomes or nanoparticles) are used to specifically deliver drugs to a site of interest. Site-direction can be achieved by attachment of targeting molecules, such as peptides, DNA/RNA, or antibodies, to the surface of the carrier. Here, the formation of polymersomes with tumor-targeting potential is described. A single-domain antibody (A12) that specifically targets PlexinD1 (a transmembrane protein overexpressed in tumor vasculature) is equipped with an azide-functionality using expressed protein ligation. This azide-containing A12 can subsequently be attached to BCN-functionalized polymersomes using a strain-promoted azide alkyne cycloaddition, thereby forming polymersomes with tumor-targeting potential.

Keywords: bioconjugation; expressed protein ligation; polymersome decoration; strain-promoted azide alkyne cycloaddition; tumor-targeting polymersomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azides / chemistry
  • Cell Adhesion Molecules, Neuronal / chemistry
  • Cell Adhesion Molecules, Neuronal / immunology
  • Drug Delivery Systems*
  • Gold / administration & dosage
  • Gold / chemistry
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Liposomes / administration & dosage
  • Liposomes / chemistry*
  • Membrane Glycoproteins
  • Metal Nanoparticles / administration & dosage
  • Metal Nanoparticles / chemistry*
  • Mice
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Single-Domain Antibodies / administration & dosage*
  • Single-Domain Antibodies / chemistry

Substances

  • Azides
  • Cell Adhesion Molecules, Neuronal
  • Intracellular Signaling Peptides and Proteins
  • Liposomes
  • Membrane Glycoproteins
  • PLXND1 protein, human
  • Single-Domain Antibodies
  • Gold